Current Measures to Prevent Late Abortion Or Prematurity

Total Page:16

File Type:pdf, Size:1020Kb

Current Measures to Prevent Late Abortion Or Prematurity Perinatology, edited by Erich Saling, Nestle" Nutrition Workshop Series, Vol. 26, Nestec, Ltd., Vevey/Raven Press, Ltd., New York © 1992. Current Measures to Prevent Late Abortion or Prematurity Erich Saling Department of Obstetrics, Berlin-Neukolln and Institute of Perinatal Medicine, Free University of Berlin, Mariendorfer Weg 28, D-I000 Berlin 44, Germany During the past few years it has been recognized more and more that ascending genital infection is an important factor in the etiology of prematurity. This is con- firmed in a number of reports in the literature. Recent reviews have been published by Romero et al. (1) and in this volume (see chapters by Eschenbach and Hobel). In a retrospective study by Schmitz, Riedewald, Schmeling, and myself (unpub- lished) we have tried to determine the cause of prematurity in 195 cases from our unit with delivery of an infant with a birth weight of less than 2,000 g and gestation less than 37 weeks. The results (Fig. 1) show that in 76% of the cases there was evidence of an infection. This means that there was direct evidence of organisms in the vagina or cervix which are known to be pathogenic or facultative pathogenic, and/or one or more of the following: raised C-reactive protein, IgA against chlamydia (never as a single parameter), leukocytosis, left shift of granulocytes, bacteriuria, abnormal placental histology, or (in several cases) manifest infections in the newborn. In 29% there was evidence of organisms as well as other signs of infection. In 47% the above-mentioned signs of infection were present but we could not find direct evidence of organisms. In cases where infection was only suspected the incidence of premature rupture of the membranes (PROM) was, as expected, very high, at between 60 and 70%. We think our results show that infection plays a considerable role in causing prematurity. In principle the course of events is as follows: a functional defect of the cervical barrier and the subsequent ascension of pathogenic organisms leads to local inflam- mation and prostaglandin release. For example, Bejar and coworkers (2) were able to show that pathogenic organisms like Bacteroides fragilis and Streptococcus vir- idans produce phospholipase A2. This stimulates the arachidonic acid metabolism in the amnion cells and prostaglandin is formed (3). It is also possible that the mi- gration of leukocytes which produces the picture of chorioamnionitis, is also able to induce intrauterine prostaglandin metabolism. According to Romero and co- workers, leukocytes are also able to induce prostaglandin synthesis through the effect of interleukin (4). 141 142 PREVENTION OF LATE ABORTION AND PREMATURITY Suspected infection without evidence of organisms 47% Only parameters of infection Additional other than infection causes PROM 62% I No cause detected Suspected infection with evidence of organisms Insufficient diagnostics 29% Only parameters of infection Other than infection causes PROM 68% 1 Additional other than infection causes |PROM33%| FIG. 1. Causes of premature labor in 195 cases (<37/0 gestational weeks and <2,000 g weight), 1988/89. Data by C. Schmitz, S. Riedewald, S. Schmeling, and E. Saling. Ascending infections reaching the membranes and decidua can, via the metabolic products of bacteria or local changes due to inflammation, lead to a lessening of the breaking strength of the lower egg pole (5) and, by stimulating prostaglandin syn- thesis, to premature rupture of the membranes and/or to premature contractions. At the beginning of the 1990s—and before infection was considered to be so im- portant in the pathogenesis of premature labor—we were able to find the first con- crete evidence that a barrier to the ascension of organisms provided much better chances of preventing late abortions or prematurity. To achieve this, since 1981 we have been using the operative early total occlusion of the external os uteri (ETCO), which provides an excellent barrier against the ascension of organisms (6,7). As this measure is only indicated in a small group of high-risk cases with a bad history, we have to search for practicable strategies to prevent dangerous ascending bacterio- logical infection that can be applied in every pregnancy. On the basis of present knowledge we have elaborated a relatively simple program suitable for daily routine use to prevent late abortions and prematurity in the future and to achieve better overall results (8). The first important step in our new program is shown in Fig. 2 as Stage I of the routine diagnostic procedures. In the very early stages of pregnancy and then at every subsequent consultation in the antenatal outpatient clinic it is possible—by PREVENTION OF LATE ABORTION AND PREMATURITY 143 Routln.: | STAGE In UN Dlractad apacial maaauraa t [STAGE 111 <3> ® © Diagnosis DIM to pravtoua I* critical ofbactorla Caryl x CRP- I (found by © kitnaeanlx, dlagnoatlca datarmi nation tha vagina, by vaginal n matarnal critical finding* aaiaallaaurtna aonography aarum ® Dlagnoala of chlamydla antlbodlaa FIG. 2. Diagnostic measures in the prematurity prevention program. simply measuring the local pH—to find out whether normal, i.e., undisturbed, con- ditions prevail in the ascending area, particularly in the vagina, so that the ascension of pathogenic organisms can be prevented by the defense mechanisms naturally pres- ent—i.e., the vagina must have a relatively high acidity. According to examinations made by our coworker I. M. Kreutzmann, the pH level—measured in the posterior fornix—should be 4.3 or even less (9). The importance of a normal acidity of the vaginal milieu has been convincingly shown by Ernest and coworkers (10). They found that patients with a mean vaginal pH above 4.5 had a threefold increased risk of premature rupture of the membranes compared with those with a mean pH of 4.5 or lower. There are three practical ways of measuring the intravaginal pH; all three can be used depending on expected accuracy and on the prevailing situation. The simplest and most precise method is to insert a pH electrode directly into the vagina and to read the pH level using a portable pH meter. The only disadvantage of this method is that the pH electrode must be disinfected after use. This takes about 15 min. The second possibility involves measuring the pH level in a vaginal smear. For this a small but nevertheless adequate amount of vaginal smear must be left on the with- drawn speculum. When the substrate is too small the measurement can be incorrect or even impossible to do. The advantage is that the pH-electrode does not have to be disinfected after use, only cleaned in tap water. The third possibility is to assess the pH level using test paper. This procedure is inexpensive and simple but unfor- tunately is not so precise as the other two more direct methods. If the routinely measured pH levels—or other factors—indicate an increased risk, then the measures shown in Stage II (Fig. 2, lower part) should be performed. These are specific diagnostic measures and are necessarily more expensive. A greater risk is present (on the left of Fig. 2): a. When indicated by past history, such as previous late abortion or premature birth, and/or when certain critical factors are present in the current pregnancy, such as 144 PREVENTION OF LATE ABORTION AND PREMATURITY poor social status, serious difficulties in professional or family life, multiple preg- nancy, uterine anomalies, etc. b. When the vaginal pH level is increased c. When the cervix is in a critical state (found by conventional vaginal examination) d. When premature contractions exist. When such indications are present, the following diagnostic measures are recom- mended (on the right of Fig. 2): 1. Bacterial cultures of the cervix and the vagina as well as of the urine 2. Examination of maternal serum for chlamydia antibodies (still controversial) 3. Assessment of the cervix by vaginal sonography 4. Determination of C-reactive protein in maternal serum. With regard to item 2, it must be said that positive chlamydia IgG and IgA results are naturally not pathognomonic for cervicitis. When there is no direct evidence of a chlamydia infection in the cervix, positive IgA may be the result of a chlamydia infection located in another region. However, when symptoms of threatened pre- mature labor are present and chlamydia antibody tests are positive, it would be careless not to treat because of uncertainty about the precise backgrounds. For this reason we think that antibiotic therapy should be used in such cases. According to a study made by our coworker E. Hansel (11), cervical assessment by vaginal sonography recommended in point 3 of Stage II appears to be more reliable than the traditional vaginal digital examination alone. If one assumes that a sono- graphically measured cervical canal length of less than 3 cm can be considered as critical, then it has been shown (Fig. 3) that when the findings on digital examination were normal, with a length of 2 cm or more, nevertheless in almost 20% (left columns) of these cases a shortened cervical canal was measured by vaginal sonography. Such shortening is often due to a three-cornered or sack-shaped hernia-like sacculation of the lower egg pole into the cervical canal in the region of the former inner os uteri. On the other hand in 46% of the cases (Fig. 3, right columns) normal cervical canal lengths were measured by vaginal sonography when short lengths of 1 cm or less had been found by palpation. C-reactive protein determination can help us in the following ways: 1. It indicates the presence of an overall reaction of the body to a bacteriologically proven ascending infection or urogenital infection and enables an assessment to be made of its degree of severity.
Recommended publications
  • XIII World Congress of Perinatal Medicine Belgrade – October 26-29, 2017
    J. Perinat. Med. 45 (2017) • Copyright © by Walter de Gruyter • Berlin • Boston. DOI 10.1515/jpm-2017-2007 47 XIII World Congress of Perinatal Medicine Belgrade – October 26-29, 2017 INVITED SPEAKERS ABSTRACTS Unauthenticated Download Date | 10/29/17 6:05 PM 48 J. Perinat. Med. 45 (2017) • Copyright © by Walter de Gruyter • Berlin • Boston. DOI 10.1515/jpm-2017-2007 A ONE YEAR REVIEW OF ECLAMPSIA IN AN ETHIOPIAN TERTIARY CARE CENTER (SAINT PAUL’S HOSPITAL MILLENNIUM MEDICAL COLLEGE, SPHMMC) Abdulfetah Abdulkadir Eclampsia remains one of the five major causes of maternal mortality in developing countries. Advances in diagnosis and management have led to a significant reduction in maternal mortality and morbidity from this disease in developed countries. In developing countries the incidence of maternal death attributed to eclampsia remains high and, in Ethiopia, maternal mortality from this complication has instead risen over the last decade. The purpose of this study was to review the incidence of eclampsia at the largest feto-maternal center in the country over one year in an attempt to determine what quality improvement measures are needed and could realistically be implemented within the system to decrease this complication. There were a total of 104 eclamptic patients during the study period. The hospital incidence of eclampsia was 82/10,000 deliveries excluding those arriving to the hospital in the postpartum period (28 cases). There were 8 maternal deaths making the case fatality rate 1 in 13 cases. The median convulsion to arrival time, referral to arrival time and magnesium sulphate administration time were found to be 3, 2 and 3 hours respectively.
    [Show full text]
  • Final Program and Abstracts PDF Download
    Celebrating Prof. Edwards’ Receiving the Nobel Prize 16th World Congress on In Vitro Fertilization 6th World Congress on In Vitro Maturation September 10-13, 2011 Tokyo, Japan Final Program and Abstracts International Society for In Vitro Fertilization with the cooperation of The Japan Society of Fertilization and Implantation Congress President: Osamu Kato (Director, Kato Ladies Clinic) Congress Vice-President: Hisao Osada (Former Professor, Nihon University) TABLE OF CONTENTS ■FINAL PROGRAM 3 Welcome Messages 7 Committees 9 Congress Information 10 Date and Venue, Contacts, Registration, Message Board, Poster Area 11 Commercial Exhibition, Lunch and Coffee 12 Instructions for Speakers and Chairpersons 14 Instructions for Poster Presenters 15 Floor Plan of the Congress Venue 16 Social Program and Travel Desks 18 Map of the Congress Venue 19 Access to the Congress Venue 20 Airport Limousine Bus Time Table 21 Local Information 27 Agenda-at-a-Glance 31 Announcement of the 17th World Congress on In Vitro Fertilization, Tunis, Tunisia 2013 32 Scientific Program 33 1. Special Guest Lecture 33 2. Opening Ceremony, Opening Lecture and Welcome Reception 33 3. Plenary Lectures 34 4. Pre-Congress Workshops 35 5. Concurrent Symposia 44 6. STGO Session 45 7. ISF Session 45 8. APART Session 46 9. Oral Communications 51 10. Poster Presentations 60 11. Luncheon Seminars ■ABSTRACTS 62 Special Guest Lecture 65 Pre-Congress Workshops 75 Plenary Lectures 90 Concurrent Symposia 219 Society Sessions 238 Oral Communications 260 Poster Presentations 305 Author Index 306 Special Guest Lecture, Pre-Congress Workshops, Plenary Lectures, Concurrent Symposia 309 Oral Communications and Poster Presentations ■CERTIFICATE 317 Certificate of Attendance (Copy) 2 WELCOME MESSAGES WELCOME MESSAGE FROM THE PRESIDENT OF ISIVF Dear Colleagues, The 16th World Congress on In Vitro Fertilization (IVF), which will be held in Tokyo Japan in September 2011, is the main International Meeting of the year focusing on IVF and Assisted Reproductive Technologies (ART).
    [Show full text]
  • International Academy of Perinatal Medicine (Iapm)
    History, Organization and Activities PREFACE Organization and Activities History, he International Academy of Perina- by Prof. Erich Saling, President of IAPM. tal Medicine (IAPM) was created in T 2005, with the agreement of the Presi- FOREWORD dents of three scientific societies: the by José M. Carrera, Secretary General ) World Association of Perinatal Medicine of IAPM. (WAPM), the European Association of Peri- CHAPTER 1 natal Medicine (EAPM) and the Internatio- The History of Perinatal Medicine. nal Society «The Fetus as a Patient» (ISFAP). IAPM ( th On the 25 of May 2005 took place the CHAPTER 2 foundational ceremony in Barcelona The fathers of Perinatal Medicine: (Spain) with venue at the Royal Academy the academic medals. of Medicine of Catalonia. CHAPTER 3 The objective of the Academy is to create a Identity and mission of International place for the studystudy, reflection, dialogue Academy of Perinatal Medicine (IAPM). INTERNATIONAL and prpromotionomotion of PPerinatal Medicine, es- CHAPTER 4 pecially on those ississues related to bioethics, History of International Academy the appropriate appapplication of the techno- of Perinatal Medicine (IAPM): ACADEMY logical advances aand the sociologic and the foundation. huhumanisticmanistic ddimensionsimensi of the fi eld. CHAPTER 5 OF PERINATAL Furthermore, the AAcademy endeavours to Constitution of IAPM and By-Laws. constitute a friendshfriendship-based bond among ththee ththreeree scscientificientifi Societies that have CHAPTER 6 sponsored its foundfoundation. Basic Organization of the IAPM. MEDICINE In the same act oof the foundation, the CHAPTER 7 members of the BBoard of the Academy The International Council: were elected. Prof. Erich Saling (Germany) Regular Fellows of IAPM. (IAPM) was elected as President,Pre and Professors CHAPTER 8 Asim Kurjak (Croati(Croatia), Aris Antsaklis (Gree- Honorary Members ce), Frank ChervenaChervenak (USA) and H.
    [Show full text]
  • Downloadable Brochure (Pdf)
    The Academy of Scholars The First Thirty Years: 1979-2009 A Brief History with Biographical Sketches of its Members 2 Annual Banquets 3 Presentation by Barbara Maria Stafford, recipient of the Bonner Award, for her book, Echo Objects: The Cognitive Work of Images Game Day 2008 – Academy of Scholars plaque shown 4 TABLE OF CONTENTS PAGE INTRODUCTION TO THE ACADEMY OF SCHOLARS ¾ Foreword by President Jay Noren 7 ¾ A Short History of the Academy 9 ¾ The Next Decade 2000‐2009 15 ¾ Members (Year of Induction) 20 ¾ Biographies 21 ¾ Other Members 97 ¾ In Memoriam 98 ¾ Presidents of the Academy 99 Appendix I By‐laws 101 Appendix II Definition of “Scholar” and “Scholarship” 104 Appendix III Administrative Assistants to the Academy 110 5 INTRODUCTION TO THE FIRST THIRTY YEARS: 1979­2009 In 1999, upon the twentieth anniversary of the founding of the Academy of Scholars, the Academy prepared a brochure, “The Academy of Scholars, The First 20 Years: 1979‐ 1999.” The brochure contained A Short History of the Academy, Biographical Sketches of Its Members, a list of other members, a Foreword by President Irvin D. Reid, an In Memoriam page, an Appendix with the By‐laws, and an Appendix with the Presidents of the Academy. The Editorial Committee for the 1999 brochure consisted of Carl Johnson, Chuan‐ pu Lee, Leonard Leone, and Guy Stern (Chair). The Editors were Ananda Prasad, Melvin Small and Guy Stern. Amanda Taylor and Todd Villeneuve served as editorial assistants. At the end of the 2007‐2008 academic year, the Academy decided to prepare an updated version of the brochure to commemorate the thirtieth anniversary of the founding of the Academy.
    [Show full text]
  • Journal of Perinatal Medicine 2017 · Volume 45 · Issue 7 · Pp
    2017·VOLUME 45·SUPPL. 2 ISSN 0936-174X JOURNAL OF PERINATAL MEDICINE JOURNAL OF PERINATAL JOURNAL OF PERINATAL MEDICINE OFFICIAL JOURNAL OF THE WORLD ASSOCIATION FULL COLOR FIGURES 2017 · VOLUME 45 · ISSUE 7 · PP. 775–910 7 · PP. 45 · ISSUE · VOLUME 2017 OF PERINATAL MEDICINE, THE INTERNATIONAL ACADEMY OF PERINATAL MEDICINE, THE NEW YORK PRINT + ONLINE NO CHARGES FOR PERINATAL SOCIETY AND THE SOCIETY THE AUTHORS FETUS AS A PATIENT ABSTRACTS 13. WORLD CONGRESS OF PERINATAL MEDICINE OCTOBER 26-29, 2017, BELGRADE AC T F TO C R A EDITOR-IN-CHIEF P M Joachim W. Dudenhausen I 2016 1.577 www.degruyter.com/journals/jpm J. Perinat. Med. 45 (2017) • Copyright © by Walter de Gruyter • Berlin • Boston. DOI 10.1515/jpm-2017-2005 3 XIII World Congress of Perinatal Medicine Belgrade – October 26-29, 2017 SCIENTIFIC PROGRAM *This version of the program has been printed by the end of September, 2017. The final program can be different from this version. J. Perinat. Med. 45 (2017) • Copyright © by Walter de Gruyter • Berlin • Boston. DOI 10.1515/jpm-2017-2005 4 World Association of Perinatal Medicine Council President: Milan Stanojevic, Croatia Past President: Aris Antsaklis, Greece President Elect: Cihat Şen, Turkey Vice Presidents: Narendra Malhotra, India Giovanni Monni, Italy Ivica Zalud, USA Secretary General: Marina Degtyareva, Russia Treasurer: Bernat Serra, Spain Deputy Secretaries: Aleksandar Ljubic, Serbia Hisham Arab, Saudi Arabia Miroslaw Wielgos, Poland Council members: Olus Api, Turkey ; Rodrigo Ayala, Mexico; Christoph Berg, Germany; Vincenzo D'Addario, Italy; Aliyu Dayabu, Nigeria; Taib Delic, Bosnia and Herzegovina; Renato Sa, Brazil; Hiroshi Sameshima, Japan; Simona Vladareanu, Romania; Tuangsit Wataganara, Thailand Editor-in-chief of the Journal Joachim W.
    [Show full text]
  • Of Young Scientists of Perinatal Medicine
    1st DEPARTMENT OF OBSTETRICS & GYNECOLOGY, UNIVERSITY OF ATHENS MEDICAL SCHOOL st 1 CONGRESS OF YOUNG SCIENTISTS OF INTERNATIONAL ACADEMY OF PERINATAL MEDICINE th First Announcement 36CONGRESS OF THE FETUS AS A PATIENT SOCIETY Crowne Plaza Hotel 25&26 April 2020 Athens-Greece LOCAL ORGANIZING COMMITTEE President: George Daskalakis Vice president: Panos Antsaklis Members: Fani Anatolitou, Aris Antsaklis, George Asimakopoulos, Aikaterini Domali, Petros Drakakis, Makarios Eleftheriades, Stavroula Gavrili, Kleanthi Gourounti, Antonia Charitou, Pelopidas Koutroumanis, Aikaterini Lykeridou, Dimitrios Loutradis, Michael Moros, Perma Panani, Vasilios Pergialiotis, Alexandros Rodolakis, Maria Simou, Michael Sindos, Athena Sou- ka, Sofoklis Stavrou, Marianna Theodora, Ioanna Tsoumpou INTERNATIONAL ACADEMY OF PERINATAL MEDICINE (IAPM) President: Asim Kurjak (Croatia) Past-President: Erich Saling (Germany) Secretary General: Frank A. Chervenak (USA) Vice-Presidents: Serge Uzan (France), Ritsuko K. Pooh (Japan), Eberhard Merz (Germany), Apostolos Papageorgiou (Canada) Treasurer: Vincenzo D’Addario (Italy) Regular Members Arnaldo Acosta (Paraguay) Amos Grunebaum (USA) Ola D. Saugstad (Norway) Aris J. Antsaklis (Greece) Asim Kurjak (Croatia) Joseph J. Schenker (Israel) Badreldeen Ahmed (Qatar) Mark Kurtser (Russia) Cihat Sen (Turkey) Birgit Arabin (Germany) Eberhard Merz (Germany) Bernat Serra (Spain) Abdellatif Ashmaig (Sudan) Giovanni Monni (Italy) Milan Stanojevic (Croatia) Chiara Benedetto (Italy) Zehra Nese Kavak (Turkey) Gennady Sukhikh (Russia)
    [Show full text]
  • Of the Fetus As a Patient Society
    UNDER THE AUSPICE OF THE MEDICAL SCHOOL 1st DEPARTMENT OF OBSTETRICS & GYNECOLOGY, UNIVERSITY OF ATHENS MEDICAL SCHOOL st 1 CONGRESS OF YOUNG SCIENTISTS OF INTERNATIONAL ACADEMY OF PERINATAL MEDICINE th Preliminary Program 36CONGRESS OF THE FETUS AS A PATIENT SOCIETY1 Crowne Plaza Hotel 25&26 April 2020 Athens-Greece LOCAL ORGANIZING COMMITTEE President: George Daskalakis Vice president: Panos Antsaklis Members: Fani Anatolitou, Aris Antsaklis, George Asimakopoulos, Antonia Charitou, Aikaterini Domali, Petros Drakakis, Makarios Eleftheriades, Stavroula Gavrili, Kleanthi Gourounti, Pelopidas Koutroumanis, Aikaterini Lykeridou, Dimitrios Loutradis, Michael Moros, Athina Moutafi, Perma Panani, Nikolaos Papantoniou, Vasilios Pergialiotis, Panagiotis Petropoulos, Alexandros Rodolakis, Maria Simou, Michael Sindos, Athena Souka, Sofoklis Stavrou, Marianna Theodora, Ioanna Tsoumpou INTERNATIONAL ACADEMY OF PERINATAL MEDICINE (IAPM) President: Asim Kurjak (Croatia) Past-President: Erich Saling (Germany) Secretary General: Frank A. Chervenak (USA) Vice-Presidents: Serge Uzan (France), Ritsuko K. Pooh (Japan), Eberhard Merz (Germany), Apostolos Papageorgiou (Canada) Treasurer: Vincenzo D’Addario (Italy) Regular Members Arnaldo Acosta (Paraguay) Amos Grunebaum (USA) Ola D. Saugstad (Norway) Aris J. Antsaklis (Greece) Asim Kurjak (Croatia) Joseph J. Schenker (Israel) Badreldeen Ahmed (Qatar) Mark Kurtser (Russia) Cihat Sen (Turkey) Birgit Arabin (Germany) Eberhard Merz (Germany) Bernat Serra (Spain) Abdellatif Ashmaig (Sudan) Giovanni Monni (Italy)
    [Show full text]
  • Nestle Nutrition Workshop Series Volume 26
    Nestle Nutrition Workshop Series Volume 26 EDITED BY ERICH SALING NESTli NUTRITION SERVICES RAVEN PRESS PERINATOLOGY Nestle Nutrition Workshop Series Volume 26 PERINATOLOGY Editor Erich Saling, M.D. Professor of Obstetrics and Perinatal Medicine Institut fur Perinatale Medizin der Freien Universitat Berlin Berlin, Germany NESTLE NUTRITION SERVICES RAVEN PRESS • NEW YORK Nestec Ltd., 55 Avenue Nestle, CH-1800 Vevey, Switzerland Raven Press, Ltd., 1185 Avenue of the Americas, New York, New York 10036 © 1992 by Nestec Ltd. and Raven Press, Ltd. All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronical, mechanical, photocopying, or recording, or otherwise, without the prior written permission of Nestec and Raven press. Made in the United States of America Library of Congress Cataloging-in-Publication Data Perinatology / editor, Erich Saling. p. cm. — (Nestle Nutrition workshop series ; v. 26) Based on the 26th Nestl6 Nutrition Workshop held in Berlin, Germany, May 14-16, 1990. Includes bibliographical references and index. ISBN 0-88167-822-8 1. Perinatology—Congresses. I. Saling, Erich. II. Nestle Nutrition Workshop (26th : Berlin, Germany : 1990) III. Series. [DNLM: 1. Fetal Monitoring—congresses. 2. Perinatology— congresses. 3. Pregnancy Complications. Infections—congresses. 4. Prenatal Diagnosis—congresses. Wl NE228 v. 26 / WQ 210 P4483 1990] RG600.P43 1991 618.3'2—dc20 DNLM/DLC for Library of Congress 91-18567 The material contained in this volume was submitted as previously unpublished material, except in the instances in which credit has been given to the source from which some of the illustrative material was derived.
    [Show full text]
  • Fetal Scalp Blood Analysis Erich Saling/ Ünit of Perinatal Medicine - the Free University of Berlin, Department of Obstetrics, Berlin-Neukölln
    Saling, Fetal scalp blood analysis 165 Fetal Scalp Blood Analysis Erich Saling/ ünit of Perinatal Medicine - The Free University of Berlin, Department of Obstetrics, Berlin-Neukölln Fetal blood analysis (FBA) is more than 2O years old. It is not only an essential part of modern supervision of the fetus during labor, but from the historical point of view it is the method which first enabled us to examine the fetus directly before birthf namely by analysing its blood. Task of FBA äs a clinical procedure FBA is a method which should be employed only äs a complemen- tary measure to continuous cardiotocography. It enables us: 1. to clarify whether or not biochemical changes confirm imminent fetal hypoxia and/or acidosis; and 2. to help in deciding whether further important clinical consequences like tocolysis (Inhibition of uterine con- tractions) or termination of the labor by Operation äre necessary. In this way it is possible to achieve a minimum of operative deliveries which is of advantage to the mothers, with an Optimum of safety for the fetus. From our many years of experience and in my own personal view/ the consistent use of fetal blood analysis could have avoided some of the problems and criticisms which occurred in some countries during the past few years in connection with intensive cardiotocographic supervision during labor and the increased caesarean section rate. Remarks on the technique For optimal results of FBA and for safeguarding of the fetus the following technical points must be especially considered: a) After drying the skin of the presenting part/ sterile parafin should be applied with a swab.
    [Show full text]
  • Programworldcongressofperinat
    1 PRE-CONGRESS COURSES - TUESDAY, 3RD NOVEMBER 10.30-17.30 ROOM CARACAS Fetal Echocardiography Course Directors: Lami Yeo (USA) and Alberto Galindo (Spain) 1. Content of a fetal cardiac examination: Guidelines proposed by professional societies. Lami Yeo (USA) 2. Methods of cardiac examination (2D, M-mode, spectral Doppler, color Doppler). Fatima Crispi (Spain) 3. Spatiotemporal image correlation (STIC) of the fetal heart: acquiring STIC volumes, evaluation of adequacy and examination of the STIC volume. Lami Yeo (USA) 4. Anatomy of the fetal heart and great vessels. Mauricio Herrera (Colombia) 5. Fetal Intelligent Navigation Echocardiography (FINE): Complexity made simple. Roberto Romero (USA) 6. Presentation of 5 cases of congenital heart disease: Just Images. Lami Yeo (USA) 7. Four-chamber view: obstructive lesions (hypoplastic left heart syndrome, hypoplastic right heart syndrome, and others). Queralt Ferrer (Spain) 8. Outflow tracts: tetralogy of Fallot, double outlet right ventricle, truncus arteriosus, transposition of great vessels. Alberto Galindo (Spain) 9. Aortic arch anomalies (coarctation of the aorta and more). Lami Yeo (USA) 10. Fetal cardiac function – evaluation of systolic and diastolic function. Fatima Crispi (Spain) 11. Extra-cardiac anomalies of the fetal thorax. Cihat Sen (Turkey) 12. Difficult cases of prenatal diagnosis. Ana Bianchi (Uruguay) 10.30-17.30 ROOM BRUSELAS Fetal Neurology Course Directors: Asim Kurjak (Croatia) and Ritsuko K. Pooh (Japan) 1. Anatomy of the central nervous system with 2D, 3D, and silhouette ultrasound. Ritsuko K. Pooh (Japan) 2. Evaluation of the central nervous system using an automatic approach. Ja Young Kwon (South Korea) 3. Diagnosis of ventriculomegaly and its clinical significance. Aris Antsaklis (Greece) 4.
    [Show full text]
  • International Scientific Achievements of Professor Erich Saling Asim Kurjak
    Herausforderungen in der Perinatal- und Geburtsmedizin Kongress zum 90. Geburtstag von Prof. Saling Samstag, 05. September 2015 - Berlin, Germany International scientific achievements of professor Erich Saling Asim Kurjak It is indeed honor and pleasure to be today here bringing congratulations for the 90th birthday to one of the “greats” in clinical medicine, to our friend and teacher professor Erich Saling. It is equally exciting to speak about Saling’s rich and dynamic international scientific profile in Berlin and Germany, birthplaces of perinatal medicine. Erich Saling has done so many contributions to perinatal medicine that I do not know where to start with reviewing them. In true sense Erich Saling’s life is characterized by series of successes approving the truth of aphorism saying that the man is born to succeed not to fail. The generation alive today is privileged to live in a remarkable age. Not only has interstellar space been spectacularly opened up to human exploration but, through a continuing medical and technological development of no less importance, “intrauterine space”, the world in which we spend our prenatal life from conception to birth, has become increasingly accessible to science. 1 The importance of perinatal medicine is growing rapidly and is making great and varied scientific progress as illustrated by 3 Textbooks of Perinatal Medicine. More and more evidence now indicates that prenatal life is a major determinant of adult heath and disease. So for instance the increasing realization that two modern epidemics – obesity and diabetes – as well as premature death from cardiovascular disease, may have their origins in environmental factors experienced during intrauterine life have given our discipline a much greater importance than anyone ever dreamed possible.
    [Show full text]
  • Some Future Aspects Within Perinatal Medicine Considered by a Senior Fellow Erich Saling
    DSJUOG Future10.5005/jp-journals-10009-1452 Aspects within Perinatal Medicine REVIEW ARTICLE Some Future Aspects within Perinatal Medicine considered by a Senior Fellow Erich Saling ABSTRACT Before the start of some selected thoughts, let me remind During the last six decades, a unique new field of applied you that our generation has the great opportunity to be medicine has been brought forward in the phase before the witness to the creation of a new medicine that started at great biological event of birth, namely into the intrauterine space. the beginning of the 1960s. On the basis of experiences collected during this time, a few For the very first time, the application of human selected thoughts about further aspects based on new but also on some old achievements are presented. medicine has been brought forward in the phase before The first one concerns the hardly necessary too frequent the great biological event of birth, and also in a new use of antibiotics with its negative side effects, such as damage widely unknown region, namely in the intrauterine space. of intestinal flora. We found convincing results in a group of We should be aware that since the beginning of our cases with premature rupture of membranes, using PVP-iodine solution for vaginal rinsing to practice in this way an efficient local obstetrical profession, the most impressive evolutionary antiseptic therapy until birth. Another example is amnioscopy, event was the great change from the predominantly unfortunately replaced to a large extent. But its use remains mother-oriented obstetrics with its considerable amount appropriate because of the low expense and high safety of of operative character to combined embryo- and fetal- this method.
    [Show full text]